Simultaneous determination of bromoxynil and MCPA in commercial samples and raw materials using reversed phase high performance liquid chromatography

Table 5 Reproducibility of the developed method for the Bromoxynil and MCPA with respect to various dosages formulations

(a) Reproducibility with respect to various dosages formulations for the Bromoxynil
Formulation	Company	Proposed method
Formulation	Company	Recovery % age	RSD %
CUT OUT 40% (EC)*	A	99.50	0.18
Bromoxynil-MCPA	B	99.97	0.14
Bromoxynil-MCPA	C	100.04	0.16
Bromoxynil-MCPA	D	100.26	0.16
Bromoxynil-MCPA	E	100.09	0.24

(b) Reproducibility with respect to various dosages formulations for the MCPA
Formulation	Company	Proposed Method
Formulation	Company	Recovery % age	RSD %
CUT OUT 40% (EC)^a	A	99.88	0.15
Bromoxynil-MCPA (EC)^a	B	100.05	0.21
Bromoxynil-MCPA (EC)^a	C	100.10	0.22
Bromoxynil-MCPA (EC)^a	D	100.35	0.17
Bromoxynil-MCPA (EC)^a	E	100.02	0.15
Walter Super (SC)^a	F	100.77	0.08

^aWhere EC stands for Emulsifiable Concentrate and SC stands for Suspension Concentrate

ISSN: 2661-801X